Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and rarely hyperviscosity.
Diagnosis: Presence… Continue reading
The National Comprehensive Cancer Network has provided a new Waldenstrom’s Macroglobuliemia Guidelines document. These are the guidelines that are followed by Medicare and many other insurance companies.
It is a good development in the education of Waldenstrom’s Macroglobulinemia.
Contributing Member – Ron Ternoway
Ron Ternoway has shared his experience with WM in “Trials of a Wally”. We thought we would share with the WMFC community!
Meletios Dimopoulos, MD
Improved understanding of Waldenström’s macroglobulinemia (WM) and expanded treatment options have made individualized treatment based on clinical indications a feasible strategy, Meletios Dimopoulos, MD, said at the 2016 Society of Hematologic Oncology annual… Continue reading